This BP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

HSBC analyst Charlene Liu downgraded the rating for Baidu, Inc. BIDU from Buy to Hold and announced a price target of $100. Baidu shares gained 2.4% to close at $88.28 on Monday. See how other analysts view this stock.
Redburn Atlantic analyst Peter Low downgraded the rating for BP p.l.c. BP from Buy to Neutral. BP shares gained 0.7% to close at $32.86 on Monday. See how other analysts view this stock.
Baird analyst Eric Coldwell downgraded McKesson Corporation MCK from Outperform to Neutral and lowered the price target from $603 to $531. McKesson shares fell 0.6% to close at $505.00 on Monday. See how other analysts view this stock.
Leerink Partners analyst Andrew Berens downgraded the rating for Regeneron Pharmaceuticals, Inc. REGN from Outperform to Market Perform, while cutting the price target from $1,175 to $1,077. Regeneron Pharmaceuticals shares fell 4.6% to close at $1,091.98 on Monday. See how other analysts view this stock.
Wedbush analyst David Chiaverini downgraded First Horizon Corporation FHN from Outperform to Neutral and slashed the price target from $20 to $17. First Horizon shares fell 1.9% to close at $15.67 on Monday. See how other analysts view this stock.